Table 1 Descriptive statistics of the 27,534 participants
| Â | GSA | CytoSNP | ||
|---|---|---|---|---|
|  | N = 17,424 | M | N = 10,110 | M |
Skin autofluorescence (SAF), AU | 1.79 [1.54, 2.09] | 0 | 1.97 [1.71, 2.28] | 0 |
lnSAF | 0.59 ± 0.22 | 0 | 0.68 ± 0.21 | 0 |
Skin reflectance, % | 0.20 [0.16, 0.25] | 0 | 0.19 [0.15, 0.23] | 0 |
Age, yrs | 42 [32, 51] | 0 | 48 [41, 55] | 0 |
Male sex, n (%) | 7092 (40.7%) | 0 | 4173 (41.3%) | 0 |
Smoking status | Â | 96 | Â | 126 |
non-smoker | 11,269 (65.0%) | Â | 6083 (60.9%) | Â |
previous smoker | 2835 (16.4%) | Â | 1753 (17.6%) | Â |
current smoker | 3224 (18.6%) | Â | 2148 (21.5%) | Â |
BMI, kg/m2 | 25.0 [22.8, 27.6] | 2 | 25.8 [23.5, 28.4] | 3 |
eGFR, ml/min/1.73m2 | 99 [88, 109] | 27 | 94 [83, 104] | 26 |
HbA1c, % | 5.4 ± 0.3 | 67 | 5.5 ± 0.3 | 23 |
HbA1c, mmol/mol | 36 ± 3 | 67 | 36 ± 3 | 23 |
Coffee drinker (> 1 cup/week) | 15,114 (87.4%) | 127 | 9238 (93.5%) | 235 |
Daily coffee consumption, cups/day | 3.3 [1.9, 4.7] | 127 | 3.7 [2.3, 5.1] | 235 |
rs1495741Â (NAT2-metabolisation status) | Â | 0 | Â | 0 |
GG (fast) | 921 (5.3%) | Â | 498 (4.9%) | Â |
GA (intermediate) | 6172 (35.4%) | Â | 3596 (35.6%) | Â |
AA (slow) | 10,331 (59.3%) | Â | 6016 (59.5%) | Â |
Inclusion mode | Â | 0 | Â | 0 |
Family doctor | 7627 (43.8%) | Â | 6218 (61.5%) | Â |
Included family members | 7393 (42.4%) | Â | 3131 (31.0%) | Â |
Self-registered | 2404 (13.8%) | Â | 761 (7.5%) | Â |